Specifically, a second booster shot will be administered to people from high-risk groups, citizens older than 60, patients with chronic fundamental diseases and those with compromised immune systems. Hong Kong-listed vaccine makers, buoyed by the news, broadly shot up.$康希諾生物(06185.HK)$rose 6.6% to $90.6, on a volume of 9.0554 million shares, involving $801 million.$RECBIO-B(02179.HK)$,$諾誠健華医薬(09969.HK)$and ...
whqqq : Will they fall after a pandemic?
Spineeスレ主 whqqq: It's hard to say
whqqq Spineeスレ主: But it can still be held for a short time, right?